Get started
Author

Angela A. Rios-Angulo

Observed names: Angela Rios-Angulo, AngelaA Rios
Institution: Farvet (Peru)
ORCID: 0000-0002-3025-543X
Observed ORCID: 0000-0002-3025-543X
OpenAlex ID: A5107977511
Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO
2021 · Gabriel Jiménez-Avalos, A. Paula Vargas-Ruiz, et al. · Scientific Reports · 47
PDF
Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
2020 · MirkoJ Zimic, AnaPaula Vargas, et al. · International Journal of Mycobacteriology · 25
Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease
2022 · Manolo Fernández Díaz, Katherine Calderón, et al. · Scientific Reports · 7
PDF
Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate
2021 · Manolo Fernandez Díaz, Katherine Calderon, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Editorial Expression of Concern: Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease
2025 · Manolo Fernández Díaz, Katherine Calderón, et al. · Scientific Reports
PDF
Preclinical Evaluation of a Newcastle Disease Virus-Vectored Intranasal SARS-CoV-2 Vaccine
2021 · Manolo Fernandez Díaz, Katherine Calderón, et al. · Research Square
PDF
Works count: 8
Citation count: 89
H-index: 4
I10-index: 2
Year
Topic
Type